Medindia

X

Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions

Tuesday, December 2, 2008 General News J E 4
Advertisement
Since 2005, UCB has awarded over half a million dollars to qualified recipients



ATLANTA, Dec. 1 /PRNewswire/ -- UCB, The Epilepsy Company(TM), will honor 31 recipients of the 2008 UCB Family Epilepsy Scholarship(TM) at a reception in Seattle, WA on Sunday, December 7 during the American Epilepsy Society Annual Meeting. The scholarship is awarded to inspiring people whose lives have been affected by epilepsy, and who seek personal growth through higher learning.



Each year, the UCB Family Epilepsy Scholarship is offered to people living with epilepsy, their caregivers and family members to provide financial support for academic and personal achievement. This year, UCB awarded a total of $150,000 to 31 recipients; twenty-one recipients are people living with epilepsy, and the remaining 10 are family members or caregivers of someone living with epilepsy.



The scholarship money can be used toward tuition at any United States-based center for higher learning, including colleges, graduate schools and technical schools. Since 2005, UCB has awarded over half a million dollars in scholarships to qualified recipients.



"There are many people living with epilepsy who continue to have a positive impact on their families, schools and communities. The UCB Family Epilepsy Scholarship allows us to recognize their achievements by making higher education more attainable for deserving recipients," said Rich Denness, Vice President and General Manager of CNS at UCB. "This scholarship is one of several innovative patient programs that demonstrate UCB's commitment to improving the lives of people living with epilepsy."



The American Epilepsy Society Annual Meeting is an international conference where medical experts convene to share research findings and discuss relevant topics in the field of epilepsy and other seizure disorders. This year the meeting will occur in Seattle, WA from December 5-9, 2008.



2008 Scholarship Recipients:

The winners of this one-time award were selected from a pool of 588 applicants. Each recipient was considered based on their application, personal essay and letters of recommendation.



2008 recipients and their selected learning institution include:



Note: Some recipients requested to remain anonymous.



About Epilepsy

Epilepsy is a chronic neurological disorder affecting approximately three million people in the US--making it more common than multiple sclerosis and Parkinson's disease combined. It is caused by abnormal, excessive electrical discharges of the nerve cells, or neurons, in the brain. Epilepsy is characterized by a tendency to have recurrent seizures and defined by two or more unprovoked seizures. There are many different seizure types and epileptic syndromes. For more information about epilepsy visit www.epilepsyadvocate.com, www.epilepsyfoundation.org or www.epilepsy.com.



About UCB

UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. Employing approximately 12,000 people in more than 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on the Euronext Brussels Exchange. Worldwide headquarters is located in Brussels, Belgium; US headquarters is located in Atlanta, Georgia. For more information about UCB, visit www.ucb-group.com.



Further Information

For more information about the UCB Family Epilepsy Scholarship(TM), please go to EpilepsyAdvocate.com and click on "Programs and Resources."



Forward Looking Statement

This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.



-Crystal Armstrong Columbus State Community College -Paul Babbitt Pitzer College -Lindsey Beth Brewer University of West Alabama -Steffanie Chamburs Seattle Pacific University -Thomas Ciccone Binghamton University -Kaycee Damm Albion College -Jordan De Jong Mitchell College -Christa Desjardins New England Culinary Institute -Courtney DiPersico Palm Beach University -Jacqueline Hayden University of Phoenix -Chelsea Henline Townson University -Cheyenne Hettel Southern State Community College -Rebecca Huang California State University Dominguez Hill -Melissa Kielbus Rochester Institute of Technology -Patrick Masterton Iowa State University -Samantha McCrary Ball State University -Jennifer Mitchell Chattahoochee Valley Community College -Meghan Monhollen Northern Kentucky University -Trevor Nuener Modesto Junior College -Allison Rellar University of Cincinnati -Ryan Schuster University of Toledo -Lakischa Stewart Thomas Jefferson University -Erin Vachon-Vierra Northern Arizona University -Brittany Wagner-Frederick Shenandoah University -Claire Willeford Georgia State University -Leigh Ann Youngblood-West Troy University

SOURCE UCB
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Tigermed Sets Up Subsidiary, Hunan Tigermed Xiangy...
S
FDA Approves Duramed's Synthetic Conjugated Estrog...